NEW YORK (GenomeWeb News) – TAP Biosystems announced today a deal with Life Technologies to combine their technologies to develop a high-throughput protein expression platform.

TAP will combine its ambr advanced micro-bioreactors with Life Tech's Expi293 Expression System for transient transfection, resulting in a platform that will increase consistency and productivity, providing researchers a tool for small volume protein expression screens and optimization of transient expression conditions, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.